(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.92%.
Sana Biotechnology's earnings in 2026 is -$234,410,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$152,041,781, with the lowest SANA earnings forecast at -$198,389,486, and the highest SANA earnings forecast at -$106,280,082. On average, 11 Wall Street analysts forecast SANA's earnings for 2027 to be -$163,335,705, with the lowest SANA earnings forecast at -$258,428,410, and the highest SANA earnings forecast at -$103,483,238.
In 2028, SANA is forecast to generate -$183,393,074 in earnings, with the lowest earnings forecast at -$255,818,022 and the highest earnings forecast at -$103,483,238.